2022 Early Hearing Detection & Intervention Virtual Conference
March 13 - 15, 2022
4/15/2013 | 2:00 PM - 3:00 PM | Auditory Neuropathy/ Dyssynchrony: How prevalent is it and what are the communication outcomes? | Solana A | 5
Auditory Neuropathy/ Dyssynchrony: How prevalent is it and what are the communication outcomes?
Information about the prevalence of bilateral and unilateral auditory neuropathy/dyssynchrony in the Colorado population of 610,829 infants screen from 2002 to 2010 will be presented. This presentation will focus on information about this population of children and the role of the medical home in the management of these children and families. Of the Colorado cohort 67 children were identified and 53 of these children had bilateral auditory neuropathy/dyssynchrony were identified. This presentation will include data on hospitals that screen with automated ABR in the well-baby nursery and the prevalence of the disorder from both the well-baby nursery and the newborn intensive care unit. Characteristics about the gender and racial/ethnic background of the identified children provide some interesting information and have implications for universal newborn hearing screening and early hearing detection and intervention systems. Almost no information is available in the literature about the developmental characteristics and outcomes of children with auditory neuropathy/dyssynchrony.
The developmental outcomes of 37 of the 53 children with bilateral auditory neuropathy/auditory dys-synchrony (AN) will be presented. Descriptive information about the percent of children with AN with cognitive disability and disabilities other than hearing loss will be presented. This is the first information on a cohort of children with bilateral auditory neuropathy/dyssynchrony on language outcomes of children with normal cognitive development. Additional information about etiologies and audiological characteristics of the children will be provided. Decision-making for amplification technology is often occuring in the first year of life. Assessment tools that have been useful in decision-making for children with auditory neuropathy/dyssynchrony will be discussed.
- identify the prevalence of auditory neuropathy/dyssynchrony in the well-baby nursery and the newborn intensive care unit in a state population
- identify the developmental characteristics of the children with auditory neuropathy/dyssynchrony and ramifications for choice of amplification technology and communication approach
- identify the role of the medical home in the management of these children
Presentation:
This presentation has not yet been uploaded.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Albert Mehl
(Co-Presenter), Kaiser Permanente, albert.mehl@kp.org;
Dr. Albert Mehl is the Chapter Champion for Colorado. He is a member of the Joint Committee on Infant Hearing representing the Academy of Pediatrics and has been a significant contributor both within the state of Colorado and nationally. He is the chairman of the American Academy of Pediatrics Task Force on Improving Newborn Hearing Screening, Diagnosis and Intervention.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
Vickie Thomson
(Co-Presenter), University of Colorado , vickie.thomson@ucdenver.edu;
Vickie Thomson, PhD, served at the Director of the Colorado Newborn Hearing Program at the Colorado Department of Public Health and Environment from 1991 to 2012. She received her master’s degree in audiology from the University of Northern Colorado in 1978 and her doctorate degree from the University of Colorado Boulder in 2007. As a clinical audiologist Vickie started one of the first infant hearing programs at Boulder Community Hospital. She has provided technical assistance in developing screening programs in Colorado and in other states and countries. She has written numerous articles on the importance of early identification and intervention of hearing loss in infants. She currently is the principle investigator if the HRSA EHDI grant and is a consultant to the National Center on Hearing Assessment and Management.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
Christine Yoshinaga-Itano
(POC,Co-Presenter), University of Colorado-Boulder, Christie.Yoshi@colorado.edu;
Dr. Christine Yoshinaga-Itano is a Research Professor in the Institute of Cognitive Science at the University of Colorado-Boulder, the Department of Otolaryngology and Audiology at the University of Colorado-Denver and the Marion Downs Center. In 1996 she developed the Marion Downs National Center. Since 1996, Dr. Yoshinaga-Itano has assisted many state departments of education and public health agencies, schools for the deaf and the blind, and early intervention programs throughout the United States and its territories. In addition, she has served as a consultant for many countries currently developing their early hearing detection and intervention programs, including the United Kingdom, Canada, Australia, New Zealand, Japan, China, Korea, Belgium, Poland, Spain, Austria, Denmark, Sweden, Norway, the Netherlands, Mexico, Chile, Argentina, Brazil, Thailand, the Philippines, and South Africa.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.
Amanda Heringer
(Author), University of Colorado-Boulder, amanda.heringer@colorado.edu;
Amanda is currently a 3rd year Au.D. student at the University of Colorado- Boulder. Amanda is originally from Bismarck, ND and obtained her undergraduate degree from Minnesota State University Moorhead. Amanda is interested in cochlear implants and pediatric audiology.
ASHA DISCLOSURE:
Financial -
Nonfinancial -